All posts tagged
Infographic: What is CAR-T Cell Therapy & How Does it Fight Cancer?
Belgian Biotech’s Leukemia CAR-T Treatment Leaves Patient Cancer-Free
British Biotech Pockets Massive Series C for its CAR-T Cancer Therapies
CAR-T is Nearly Here: How Will It Be Delivered?
The CAR-T Race is Far from Over: This CEO is Exploring a New Avenue
French CAR-T Company Halts Clinical Trials Because of a Patient Death
The FDA Approves the First CAR-T Cell Therapy for Cancer
Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks
Update: The FDA Unanimously Recommends Approval of the First CAR-T Therapy
American CAR-T Leader Eyes Europe, Initiating Market Approval Process & Clinical Trial
French Biotech gets an EU CRISPR Patent for CAR-T Research
Celyad Starts a Third CAR-T Trial, in Metastatic Colorectal Cancer
Labiotech UG, All Rights Reserved -
Send this to a friend